Federal Criminal Charges for Importing Nitazene Pills Into the United States
Nitazenes are an increasingly important category of synthetic opioids appearing in the illicit drug supply in the United States. In some cases, nitazenes are sold as powders or other drugs; in others, they are pressed into counterfeit prescription pills designed to resemble oxycodone, hydrocodone, or other pharmaceutical medications.
For someone accused of importing nitazene pills into the United States, the potential federal consequences can be severe. Depending on the substance involved, the quantity, the defendant’s conduct, and whether anyone suffered serious injury or death, federal prosecutors may bring charges carrying penalties ranging from several years in prison to life imprisonment.
The federal statutes governing these cases are also evolving. In particular, the Drug Enforcement Administration (DEA) has continued to place additional nitazene compounds into Schedule I of the federal Controlled Substances Act.
What Are Nitazenes?
“Nitazenes” refers to a family of synthetic opioids, including substances such as protonitazene, metonitazene, isotonitazene, and related compounds. According to the DEA, nitazenes can match or exceed the potency of fentanyl and have increasingly been detected mixed with fentanyl, heroin, cocaine, and other drugs. Nitazenes were never approved for medical use in the United States.
This creates a significant federal criminal-law issue because many nitazenes are controlled substances under the Controlled Substances Act (CSA). Some compounds have been individually placed in Schedule I, while federal law may also apply to qualifying controlled-substance analogues.
The scheduling landscape has continued to develop. For example, DEA temporarily placed N-pyrrolidino metonitazene and N-pyrrolidino protonitazene into Schedule I in August 2025. DEA subsequently issued a final order permanently placing both substances in Schedule I, effective February 11, 2026.
Importing Nitazene Pills Can Constitute a Federal Felony
The principal federal importation statute is 21 U.S.C. § 960.
Section 960 makes it unlawful to knowingly or intentionally import a controlled substance contrary to the federal import/export provisions of the Controlled Substances Act, including 21 U.S.C. §§ 952 and 957.
In a typical case involving pills mailed or shipped from another country, federal prosecutors could allege that the defendant knowingly caused a controlled substance to be imported into the United States. The government’s theory may focus on the person who physically brought the drugs across the border, but it can also reach people who allegedly arranged, financed, directed, or facilitated the shipment.
The precise charges depend heavily on the facts.
21 U.S.C. § 952 — Importation
Section 952 generally prohibits the importation into the United States of controlled substances except as authorized by federal law.
A person does not necessarily have to personally cross an international border carrying the drugs to face an importation charge. Prosecutors may allege that a defendant arranged for drugs to be shipped into the United States or otherwise knowingly participated in the importation.
21 U.S.C. § 960 — Importation Penalties
Section 960 establishes the criminal penalties for unlawful importation.
For a Schedule I or Schedule II controlled substance that does not fall within one of the statute’s specified quantity-based categories, § 960(b)(3) provides for up to 20 years in federal prison. If the use of the substance results in death or serious bodily injury, the penalty can increase to 20 years to life imprisonment. A prior qualifying felony drug conviction can also substantially increase the potential penalty.
The statute also authorizes substantial criminal fines. For an individual, the maximum fine under § 960(b)(3) can be $1 million, subject to the statutory provisions governing the particular offense and defendant.
That means a defendant charged with importing a Schedule I nitazene may face a very serious felony even when the amount involved does not trigger one of the statute’s higher quantity-based mandatory minimums.
Conspiracy Charges Can Be Added
Federal prosecutors frequently charge conspiracy in significant drug-importation investigations.
Two statutes can be particularly important:
- 21 U.S.C. § 963 — conspiracy to import or export controlled substances; and
- 21 U.S.C. § 846 — conspiracy to manufacture, distribute, or possess controlled substances with intent to distribute.
A conspiracy charge can be significant because the government does not necessarily have to prove that the defendant personally possessed every package or personally crossed the border.
Instead, prosecutors generally attempt to establish that the defendant knowingly joined an agreement to commit the underlying drug offense and that the required overt conduct or other statutory elements were satisfied.
For an international operation, the government may rely on evidence such as communications with overseas suppliers, payment records, cryptocurrency transactions, shipping records, package-tracking information, customs records, emails, text messages, and statements by cooperating witnesses.
Importation Is Different From Possession With Intent to Distribute
An important distinction in nitazene cases is that importation and domestic drug trafficking are separate offenses.
A person could potentially face charges for both importing the drugs and later possessing or distributing them.
For example, prosecutors might allege that a defendant:
- arranged for nitazene powder or pills to be shipped from overseas;
- caused the drugs to enter the United States;
- took possession of the shipment;
- stored the drugs at a residence or warehouse; and
- distributed the pills to customers.
Depending on the evidence, prosecutors could charge different portions of that conduct under §§ 952, 960, 841, 846, and 963.
The distinction can matter greatly at sentencing because different offenses can involve different statutory penalties and sentencing calculations.
Counterfeit Pills Create Additional Risks
Nitazene cases frequently involve pills that are represented as legitimate prescription medications.
That can create additional federal criminal exposure.
For example, a shipment described as legitimate pharmaceutical products may generate allegations that the defendant used false declarations, fraudulent shipping information, or other deceptive means to bring the drugs into the country.
The government may also investigate whether the pills were manufactured or distributed as counterfeit pharmaceuticals and whether other federal statutes apply.
More importantly, the fact that the pills resemble legitimate medication does not make the underlying controlled substance legally permissible. A blue pill represented as oxycodone, for example, may nevertheless be treated as a controlled substance containing a synthetic opioid if laboratory testing establishes that it contains a scheduled nitazene.
Recent Federal Nitazene Cases
Federal prosecutors have increasingly brought cases involving nitazenes and international supply chains.
China-Based Companies Charged With Importing Protonitazene and Metonitazene
In 2023, the Justice Department announced indictments involving several China-based chemical companies and individuals allegedly involved in the international supply of synthetic opioids.
One particularly significant indictment charged Jiangsu Bangdeya New Material Technology Company and an alleged operator with conspiracy to import protonitazene and metonitazene, conspiracy to distribute those substances, and multiple distribution offenses. According to the Justice Department, the company allegedly advertised protonitazene and metonitazene for sale online and had imported significant quantities into the United States.
The same federal investigation also resulted in charges against other China-based companies for alleged attempted importation of protonitazene. The Justice Department reported that Guangzhou Tengyue Chemical Co. Ltd. and Xiaojun Huang were charged with attempted importation of protonitazene, while several other companies and individuals faced similar allegations.
These cases illustrate an important point: the government can pursue the overseas supplier as well as individuals involved in the United States distribution network.
South Florida Protonitazene Conspiracy
In January 2024, a South Florida defendant pleaded guilty to participating in a conspiracy to possess with intent to distribute protonitazene. The Justice Department described the case as involving protonitazene originating from China.
The case demonstrates how federal prosecutors can use conspiracy statutes to pursue participants in an international supply chain even when the defendant’s role is not limited to personally carrying drugs across a border.
Metonitazene and Other Nitazenes in Later Federal Cases
Nitazene prosecutions have continued beyond the initial wave of protonitazene cases.
In January 2025, for example, a South Florida defendant was sentenced to 180 months—15 years—in federal prison after pleading guilty to possessing with intent to distribute metonitazene, N-desethyl isotonitazene, and methamphetamine.
In July 2025, two Louisville defendants were sentenced to 10 years in federal prison for trafficking methamphetamine, metonitazene, and fentanyl.
And in August 2025, three South Florida residents were sentenced in a case involving a conspiracy to distribute fentanyl and N-pyrrolidino protonitazene.
These cases show that prosecutors are not treating nitazenes as an obscure or merely theoretical category of controlled substances. Federal authorities are actively investigating and prosecuting their manufacture, importation, possession, and distribution.
Cases Resulting in Death or Serious Bodily Injury
The stakes become substantially higher when prosecutors allege that a person’s drug distribution caused death or serious bodily injury.
Section 960 provides that a Schedule I importation offense that results in death or serious bodily injury can carry 20 years to life imprisonment.
There have already been particularly serious federal prosecutions involving protonitazene.
In November 2024, federal prosecutors in California charged a defendant with distributing protonitazene resulting in death. The Justice Department described the prosecution as believed to be the nation’s first death-resulting criminal case involving that narcotic.
Importantly, an allegation that a drug caused a death does not automatically establish criminal liability. The government still has to prove the elements of the charged offense beyond a reasonable doubt, including the required mental state and causation requirements.
The Controlled Substance Analogue Act May Also Matter
One complication in synthetic-opioid prosecutions is that chemists can modify the molecular structure of an existing drug.
Congress addressed this issue through the federal Controlled Substance Analogue provisions, including 21 U.S.C. § 813.
In appropriate circumstances, a substance that is not expressly listed in a schedule may nevertheless be treated as a Schedule I controlled substance if it qualifies as a controlled-substance analogue under federal law and is intended for human consumption.
This can become an important issue when prosecutors charge a relatively new synthetic opioid whose precise chemical structure differs from a substance already listed in Schedule I.
However, whether a particular compound qualifies as a controlled-substance analogue can involve complicated questions of statutory interpretation, chemistry, intended use, and the government’s proof. It should not be assumed simply because prosecutors refer to a substance as a “nitazene.”
What Does the Government Have to Prove?
In a federal importation prosecution, the government generally must establish the elements of the particular offense beyond a reasonable doubt.
For a typical § 960 importation case, issues can include:
- whether the substance was a federally controlled substance;
- whether the substance actually crossed—or was attempted to be brought across—the U.S. border;
- whether the defendant knowingly and intentionally participated in the importation;
- whether the defendant knew the relevant facts concerning the substance;
- the defendant’s role in the transaction;
- the quantity and chemical identity of the substance; and
- whether additional facts trigger enhanced penalties.
Knowledge can be one of the most heavily contested issues in a case involving counterfeit pills or international shipments.
A defendant who claims to have believed that a package contained a lawful chemical or legitimate medication may present a very different factual and legal case from someone accused of knowingly ordering kilograms of a controlled synthetic opioid.
Federal Sentencing Can Be Driven by the Drug, Quantity, and Conduct
A conviction does not automatically result in the maximum statutory sentence.
Federal judges generally consider the statutory penalties, the U.S. Sentencing Guidelines, the defendant’s criminal history, the defendant’s role in the offense, obstruction or acceptance of responsibility, and other applicable sentencing factors.
In a nitazene case, the quantity and identity of the substance can be particularly important.
So can evidence that the defendant was an organizer or leader, evidence of sophisticated international trafficking, possession of firearms, obstruction of justice, prior felony drug convictions, or conduct involving multiple controlled substances.
Conversely, a defendant’s limited role, lack of criminal history, cooperation, and acceptance of responsibility may become important sentencing considerations where legally applicable.
Potential Federal Charges in a Nitazene Importation Case
Depending on the facts, an investigation involving imported nitazene pills could potentially result in charges such as:
| Federal statute | Potential offense |
|---|---|
| 21 U.S.C. § 952 | Unlawful importation of a controlled substance |
| 21 U.S.C. § 960 | Penalties for unlawful importation/exportation |
| 21 U.S.C. § 963 | Conspiracy to import or export a controlled substance |
| 21 U.S.C. § 841 | Distribution or possession with intent to distribute |
| 21 U.S.C. § 846 | Drug-trafficking conspiracy |
| 21 U.S.C. § 813 | Treatment of qualifying controlled-substance analogues as Schedule I substances |
| 18 U.S.C. § 2 | Aiding and abetting, where applicable |
| 18 U.S.C. § 1956/1957 | Potential money-laundering charges involving drug proceeds, depending on the facts |
The government does not have to limit itself to one theory. An investigation may result in multiple counts arising from different aspects of the alleged conduct.
Why Nitazene Importation Cases Are Particularly Serious
Nitazene importation investigations combine several areas of federal law enforcement priority: international drug trafficking, synthetic opioids, counterfeit pharmaceuticals, darknet or online sales, cryptocurrency, international shipping, and transnational criminal organizations.
The federal government’s response has reflected that combination.
DEA specifically identifies nitazenes as an emerging synthetic-opioid threat, while recent prosecutions demonstrate that federal authorities are targeting both domestic distributors and overseas suppliers.
For a person under investigation, the distinction between a package containing a legal chemical and one containing a Schedule I synthetic opioid can therefore have enormous consequences.
The Bottom Line
Importing nitazene pills into the United States can expose a defendant to serious federal felony charges. The central statutes are generally 21 U.S.C. §§ 952 and 960, with conspiracy and trafficking statutes potentially adding additional counts.
For many Schedule I nitazene importation offenses, the statutory maximum can reach 20 years in federal prison, while cases involving death or serious bodily injury can carry 20 years to life. Prior qualifying drug convictions can further increase the penalties.
The rapidly changing status of synthetic opioids makes these cases particularly complex. DEA has continued to add individual nitazene compounds to Schedule I, and federal prosecutors have already brought international importation and distribution cases involving protonitazene and metonitazene.
Anyone investigated or charged in such a case should have counsel examine the precise chemical identity of the substance, its federal scheduling status at the time of the alleged conduct, the government’s evidence concerning knowledge and intent, the chain of custody and laboratory analysis, the defendant’s role in the transaction, and the statutory and Guidelines consequences of each potential charge.
Matthew Galluzzo is a former Manhattan prosecutor and experienced federal criminal defense attorney in New York City. He has successfully defended many individuals accused of federal narcotics importation crimes, including narcotics, controlled substances, and precursor chemicals. If you or a loved one have been arrested and charged with a crime involving the importation of nitazene or some other controlled substance, you should seriously consider contacting him to discuss his engagement.